Podcasts about cancer treatment

"Any time the patient hears the word 'cancer,' they shut down a little bit, right? They may not hear everything that the oncologist or urologist, or whoever is talking to them about their treatment options, is saying. The oncology nurse is a great person to sit down with the patient and go over the information with them at a level they can understand a little bit more. To go over all the treatment options presented by the physician, and again, make sure that we understand their goals of care," ONS member Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, manager of clinical education and clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about prostate cancer treatment considerations for nurses.  Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by November 21, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the treatment of prostate cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 387: Prostate Cancer Screening, Early Detection, and Disparities Episode 373: Biomarker Testing in Prostate Cancer Episode 324: Pharmacology 101: LHRH Antagonists and Agonists Episode 321: Pharmacology 101: CYP17 Inhibitors Episode 208: How to Have Fertility Preservation Conversations With Your Patients Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: Communication Models Help Nurses Confidently Address Sexual Concerns in Patients With Cancer Exercise Before ADT Treatment Reduces Rate of Side Effects Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer Nurses Are Key to Patients Navigating Genitourinary Cancers Sexual Considerations for Patients With Cancer The Case of the Genomics-Guided Care for Prostate Cancer ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (Second Edition) Manual for Radiation Oncology Nursing Practice and Education (Fifth Edition) Clinical Journal of Oncology Nursing articles: Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers Physical Activity: A Feasibility Study on Exercise in Men Newly Diagnosed With Prostate Cancer The Role of the Advanced Practice Provider in Bone Health Management for the Prostate Cancer Population Oncology Nursing Forum articles: An Exploratory Study of Cognitive Function and Central Adiposity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer ONS Guidelines™ for Cancer Treatment–Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer Other ONS resources: Biomarker Database (refine by prostate cancer) Biomarker Testing in Prostate Cancer: The Role of the Oncology Nurse Brachytherapy Huddle Card External Beam Radiation Huddle Card Hormone Therapy Huddle Card Luteinizing Hormone-Releasing Hormone Antagonist Huddle Card Sexuality Huddle Card American Cancer Society prostate cancer page National Comprehensive Cancer Network homepage To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org Highlights From This Episode "I think it's important to note that urologists are usually the ones that are doing the diagnosis of prostate cancer and really start that staging of prostate cancer. And the medical oncologists usually are not consulted until the patient is at a greater stage of prostate cancer. I find that it's important to state because a lot of our patients start with urologists, and by the time they've come to us, they're a lot further staged. But once a prostate cancer has been suspected, the patient needs to be staged for the extent of disease prior to that physician making any treatment recommendations. The staging includes doing a core biopsy of the prostate gland. During this core biopsy, they take multiple different cores at different areas throughout the prostate to really look to see what the cancer looks like." TS 1:46 "[For] the very low- and low-risk group, the most common [treatment] is active surveillance. ... Patients can be offered other options such as radiation therapy or surgery if they're not happy with active surveillance. ... The intermediate-risk group has favorable and unfavorable [status]. So, if they're a favorable, their Gleason score is usually a bit lower, things are not as advanced. These patients are offered active surveillance and then either radical prostatectomy with possible removal of lymph nodes or radiation—external beam or brachytherapy. If a patient has unfavorable intermediate risk, they are offered radical prostatectomy with removal of lymph nodes, external radiation therapy plus hormone therapy, or external radiation with brachytherapy. All three of these are offered to patients, although most frequently we see that our patients are taken in for radical prostatectomy. For the high- or very high-risk [group], patients are offered radiation therapy with hormone therapy, typically for one to three years. And then radical prostatectomy with removal of lymph nodes could also be offered for those patients." TS 7:55 "Radiation can play a role in any risk group depending on the patient's preference. ... The types of radiation that we use are external beam, brachytherapy, which is an internal therapy, and radiopharmaceuticals, [which are] more for advanced cancer, but we are seeing them used in prostate [cancer] as well. External beam radiation focuses on the tumor and any metastasis we may have with the tumor. It can be used in any risk [group] and for recurrence if radiation has not been done previously. If a patient has already been radiated to the pelvic area or to the prostate, radiation is usually not given again because we don't want to damage the patient any further. Brachytherapy is when we put radioactive pellets directly into the prostate. For early-stage prostate cancer, this can be given alone. And for patients who have a higher risk of the cancer growing outside the prostate, it can be given in combination with external beam radiation. It's important to note with brachytherapy, it cannot be used on patients who've had a transurethral resection of the prostate or any urinary problems. And if the patient has a large prostate, they may have to be on some hormone therapy prior to brachytherapy, just to shrink that prostate down a little bit to get the best effect. ... Radiopharmaceuticals treat the prostate-specific membrane antigen." TS 11:05 "The side effects of surgery are usually what deter the patient from wanting surgery. The first one is urinary incontinence. A lot of times, a patient has a lot of urinary incontinence after they have surgery. The other one is erectile dysfunction. A lot of patients may not want to have erectile dysfunction. Or, if having an erection is important to the patient, they may not want to have surgery to damage that. In this day and age, physicians have gotten a lot better at doing nerve-sparing surgeries. And so they really do try to do that so that the patient does not have any issues with erectile dysfunction after surgery. But [depending on] the extent of the cancer where it's growing around those nerves or there are other things going on, they may not be able to save those nerves." TS 15:26 "Luteinizing hormone-releasing hormone, or LHRH antagonists or analogs, lower the amount of testosterone made by the testicles. We're trying to stop those hormones from growing to prevent the cancer. ... When we lower the testosterone very quickly, there can be a lot more side effects. But if we lower it a little bit less, we can maybe help prevent some of them. The side effects are important. When I was writing this up, I was thinking, 'Okay, this is basically what women go through when they go through menopause.' We're decreasing the estrogen. We're now decreasing the testosterone. So, the patients can have reduced or absent sexual desire, they can have gynecomastia, hot flashes, osteopenia, anemia, decreased mental sharpness, loss of muscle mass, weight gain, and fatigue." TS 17:50 "What we all need to remember is that no patient is the same. They may not have the same goals for treatment as the physicians or the nurses want for the patient. We talked about surgery as the most common treatment modality that's presented to patients, but it's not necessarily the option that they want. It's really important for healthcare professionals to understand their biases before talking to the patients and the family. It's also important to remember that not all patients are in heterosexual relationships, so we need to explain recovery after treatment to meet the needs of our patients and their sexual relationships, which is sometimes hard for us. But remembering that—especially gay men—they may not have the same recovery period as a heterosexual male when it comes to sexual relationships. So, making sure that we have those frank conversations with our patients and really check our biases prior to going in and talking with them." TS 27:16

In this episode, host Shikha Jain, MD, speaks with Jason Williams, MD, and Nathan Goodyear, MD, about innovations in immunotherapy, the future of cancer care and more. •    Welcome to another exciting episode of Oncology Overdrive 1:02 •    About Williams 1:12 •    About Goodyear 1:56 •    The interview 3:08 •    Nathan, can you explain the concept of your medical philosophy, Docēre rāphè, and how you integrate it into your practice? 3:29 •    Jason, how did you get to where you are today, and how did you end up founding the Williams Cancer Institute? 5:28 •    Nathan, as an OB-GYN and lifestyle physician, what was your path to this space and at Williams Cancer Institute? 14:22 •    How do you both navigate being creative in the current climate of misinformation from a patient and physician standpoint?  20:17 •    Jason, what are the benefits and challenges of practicing in other countries versus in the United States? 26:05 •    Discussion on patient education through scientific evidence and innovation. 31:00 •    If someone could only listen to the last minute of this episode, what would you want listeners to take away? 33:37 •    How to contact Goodyear & Williams 35:42 •    Thanks for listening 36:11 Jason Williams, MD, DABR, is a medical doctor, board-certified radiologist and image-guided cancer specialist. As a leader in immunotherapy, he performed the world's first ablation procedure combined with intra-tumoral immunotherapy injections. Dr. Williams serves as the Director of Interventional Oncology and Immunotherapy at the Williams Cancer Institute, which he founded to advance innovative cancer treatments. Nathan Goodyear, MD, MD(H), is an integrative medicine physician, board-certified in obstetrics and gynecology, and a leader in wellness and cancer prevention. He specializes in functional and regenerative medicine, focusing on healing and teaching the body to restore itself. Dr. Goodyear works at the Williams Cancer Institute, pioneering innovative cancer care with a holistic approach. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Goodyear and Williams can be reached at williamscancerinstitute.com. Disclosures: Jain, Goodyear and Williams report no relevant financial disclosures. 

Could the future of cancer treatment be natural, non-toxic, and even anti-aging? In this episode of The Aging Well Podcast, Dr. Jeff Armstrong welcomes Dr. Jeff Gross, founder of ReCELLebrate and a pioneer in regenerative stem cell and exosome medicine.Dr. Gross explains how activated Natural Killer (NK) cell-derived exosomes are changing the way we approach cancer treatment and immune health—offering a powerful, non-toxic alternative to chemotherapy and radiation. He reveals how these therapies boost the body's natural defense systems, eliminate cancer and “zombie” cells that accelerate aging, and help restore vitality without harming healthy tissue.We'll explore what makes NK cell exosome therapy unique, how it might serve as both treatment and prevention, and its potential role in the future of anti-aging medicine.Whether you're interested in cancer care, longevity science, or breakthroughs in immunotherapy, this conversation could change the way you think about health, healing, and aging well.Learn more at https://recellebrate.com/Please, support The Aging Well Podcast by hitting the ‘like' button, subscribing/following the podcast, sharing with a friend, and….BUY the products you need to… age well from our trusted affiliates and support the mission of The Aging Well Podcast*.The Aging Well Podcast merchandise | Show how you are aging well | Use the promo code AGING WELL for free shipping on orders over $75 | https://theagingwellpodcast-shop.fourthwall.com/promo/AGINGWELLAuro Wellness | Glutaryl—Antioxidant spray that delivers high doses of glutathione (“Master Antioxidant”) | 10% off Code: AGINGWELL at https://aurowellness.com/agingwellpodcastBerkeley Life | Optimize nitric oxide levels | Purchase your starter kit at a 15% discount | Use the promo code: AGINGWELL15 | https://berkeleylife.pxf.io/c/6475525/3226696/31118Oxford Healthspan | Primeadine®, a plant-derived spermidine supplement | 10% off code: AGINGWELL | https://oxford-healthspan.myshopify.com/AgingWellProlon | The Fasting Mimicking Diet (FMD) is a revolutionary five-day nutrition program scientifically formulated to mimic the effects of a prolonged water fast while still allowing nourishment - supporting the benefits of fasting without the challenges and risks that come from water-only fasts. | For the best available discount always use this link: https://prolonlife.com/theagingwellpodcastL-Nutra Health | The medical division of L-Nutra, focused on helping people manage and potentially reverse chronic health conditions, like type 2 diabetes, prediabetes, insulin resistance, and obesity, using personalized, lifestyle-based programs grounded in evidence, not prescriptions. | Use this link: https://l-nutrahealth.com/theagingwellpodcastThrive25—Your personal longevity advisor | https://www.thrive25.com/early-access?via=william-jeffreyFusionary Formulas | Combining Ayurvedic wisdom with Western science for optimal health support. | 15% off Code: AGINGWELL | https://fusionaryformulas.com/Jigsaw Health | Trusted supplements. “It's fun to feel good.” | Click the following link for 10% off: https://www.jigsawhealth.com/?rfsn=8710089.1dddcf3&utm_source=refersion&utm_medium=affiliate&utm_campaign=8710089.1dddcf3Dr Lewis Nutrition | Fight neurodegeneration and cognitive decline with Daily Brain Care by Dr Lewis Nutrition—a proven daily formula designed to protect and restore brain function. | 10% off code: AGINGWELL or use the link: https://drlewisnutrition.com/AGINGWELLTruDiagnostic—Your source for epigenetic testing | 12% off Code: AGEWELL or use the link: https://shop.trudiagnostic.com/discount/AGEWELL*We receive commission on these purchases. Thank you.

Tonight on The Brian Crombie Hour, Brian sits down with friend and advisor Pierre-Jean Esmieu-Fournel, a Paris-based financier whose life story and sharp analysis cut through the noise on Europe's economic crisis. PJ shares his experience inside France's welfare state including fully covered metastatic cancer treatment worth €320,000/year, and why the system is now at a breaking point, France's fiscal reality, and a political system in turmoil. He also discusses retirement ages, pension models, health-care tradeoffs, and demographic pressures hitting all three nations.

BUFFALO, NY – November 18, 2025 – A new #review was #published in Oncotarget (Volume 16) on November 14, 2025, titled “Mechanism of anticancer action of bifidobacterium: Insights from gut microbiota.” This review, led by first author Hoang Do and correspondent author Ashakumary Lakshmikuttyamma from Thomas Jefferson University, explores how bifidobacterium, a common probiotic found in the gut, may contribute to cancer prevention and therapy. By analyzing existing studies, the authors highlight the growing importance of gut health in cancer treatment and shed light on how bifidobacterium could complement standard cancer therapies. Bifidobacterium is widely known for promoting digestive health and is often included in fermented foods and dietary supplements. However, emerging evidence suggests it may also play a broader role in immune regulation and cancer defense. The review explains how certain strains of bifidobacterium may enhance the effectiveness of chemotherapy, radiation, and immunotherapy in cancers such as breast, lung, colorectal, and gastric cancers. According to the review, bifidobacterium influences cancer outcomes through several biological mechanisms. It helps regulate immune function by reducing inflammation and supporting the activity of immune cells that target tumors. For instance, strains like B. longum and B. breve have been shown to lower levels of harmful inflammatory markers and boost anti-inflammatory responses. These changes can make cancer treatments more effective while also reducing side effects. “Presence of Bifidobacterium breve in gut microbiota extended the median progression-free survival of NSCLC patients.” The review also discusses how bifidobacterium helps detoxify the body by breaking down cancer-causing compounds and limiting their ability to damage cells. In preclinical studies, the probiotic reduced the activity of enzymes that produce carcinogens and helped in converting food-based substances into cancer-fighting agents. Some strains were even found to suppress genes that promote tumor growth and increase molecules that trigger cancer cell death. The authors emphasize that diet plays a critical role in supporting the growth of bifidobacterium. Foods rich in dietary fiber, especially those containing inulin and oligosaccharides like garlic, onions, or leeks, can help increase its levels in the gut. This suggests that simple dietary changes could not only improve gut health but also support cancer prevention and treatment strategies. Although the review presents compelling evidence, the authors stress the need for more clinical trials to determine how different strains of bifidobacterium affect specific types of cancer. Personalized approaches may be necessary to match the right probiotic strains with individual treatment plans. As research continues to uncover the link between gut microbes and cancer, bifidobacterium stands out as a promising natural ally that could enhance the body's defenses and improve cancer treatment outcomes. DOI - https://doi.org/10.18632/oncotarget.28779 Correspondence to - Ashakumary Lakshmikuttyamma - axl025@jefferson.edu Abstract video - https://www.youtube.com/watch?v=KTWJDAN15lY Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28779 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Kaylynne Bantom, People’s Post journalist spoke to Clarence Ford about the news waking waves in the Southern Suburbs. Views and News with Clarence Ford is the mid-morning show on CapeTalk. This 3-hour long programme shares and reflects a broad array of perspectives. It is inspirational, passionate and positive. Host Clarence Ford’s gentle curiosity and dapper demeanour leave listeners feeling motivated and empowered. Known for his love of jazz and golf, Clarrie covers a range of themes including relationships, heritage and philosophy. Popular segments include Barbs’ Wire at 9:30am (Mon-Thurs) and The Naked Scientist at 9:30 on Fridays. Thank you for listening to a podcast from Views & News with Clarence Ford Listen live on Primedia+ weekdays between 09:00 and 12:00 (SA Time) to Views and News with Clarence Ford broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/erjiQj2 or find all the catch-up podcasts here https://buff.ly/BdpaXRn Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

Biochemist Lingyin Li survived breast cancer at just 30 and now works to harness the human immune system to fight cancers that have long evaded treatment. T cells, she says, are powerful cancer killers, but they can be oblivious. She and her lab colleagues have discovered a masking enzyme that squelches the immune system's “danger signals” and are now developing drugs to block that enzyme. She likens her work to an arms race between cancer and immunotherapy. “The cancers are not getting smarter, but we are,” Li tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Lingyin LiConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest Lingyin Li, a professor of biochemistry at Stanford University.(00:03:38) Research MotivationLingyin explains how her breast cancer diagnosis inspired her research.(00:04:31) How T-Cells WorkT-cell mechanisms and why they struggle to reach solid tumors.(00:05:38) Immune System OverviewInnate and adaptive immunity and how mutations make cancer recognizable.(00:07:28) Awakening the Immune SystemEfforts to stimulate innate immune cells to detect and expose tumors.(00:10:54) The Cancer SignalDiscovery of cancer-derived DNA signals that alert the immune system.(00:13:01) Cancer's Evasion MechanismHow tumors destroy immune signals to hide from detection.(00:14:26) ENPP1 EnzymeIdentification of ENPP1 as the enzyme enabling immune evasion.(00:15:22) Balancing Immunity and SafetyRole of ENPP1 in autoimmunity and the challenge of targeting it safely.(00:19:30) ENPP1 InhibitorsDevelopment of molecules to block ENPP1 and enhance immune signaling.(00:24:55) Preclinical FindingsThe promising results against aggressive solid tumors in animal studies(00:28:05) From Lab to ClinicThe progress toward FDA approval and preparation for human testing.(00:31:04) Future In a MinuteRapid-fire Q&A: innovation, collaboration, and the outlook for cancer treatment.(00:33:14) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

A breakthrough that could reshape cancer treatment.GT Biopharma (NASDAQ: GTBP) is advancing its next generation TriKE® platform, an innovative immunotherapy that activates the body's own natural killer cells to identify and destroy cancer. In this interview, Executive Chairman & CEO Michael Breen discusses the company's latest clinical progress and the potential of its lead drug candidate, GTB-3650.He also shares insights into the science behind TriKE®, the company's pipeline for solid tumors and autoimmune diseases, and its mission to develop more humane cancer therapies that bring real hope to patients worldwide.Learn more about GT Biopharma: https://www.gtbiopharma.com/Watch the full YouTube interview here: https://youtu.be/jduKYNKHMIYAnd follow us to stay updated: https://www.youtube.com/@GlobalOneMedia

"What am I holding onto so tightly that I would never change?"  Our guest last week (and the week before!), Becca, once declared she'd never undergo treatment again—until her cancer returned and she found herself asking how they'd treat it. We often know exactly what we're going to do in difficult situations...until we don't. This week, Cody reflects on psychological flexibility and the profound courage it takes to change your mind. Why we hold so tightly to old stances, the hubris of declaring what we'd do in someone else's situation, and the strength required to grow and evolve. Join Cody for this brief but powerful exploration of identity, humility, and the grace of changing course. --- For more information on the sponsor of this episode, please visit the Iliff Death Care Collective.

Fasting and intermittent fasting have been in the news in recent months. In this episode, Faiza Kalam, PhD, MD, director of the James Food, Activity Sleep and Time (FACT) Lab explains the basics and how fasting and intermittent fasting can lead to improved cholesterol, LDL and blood pressure levels and rates and help people lose weight without the use of weight-reducing drugs that can have side effects. Fasting can also help cancer patients during their treatment. “The initial research has shown there is less fatigue and better quality of life for cancer patients during chemotherapy treatment who fast,” said Kalam.

Martha Sklavos is the founder and CEO of Aloe Therapeutics, she’s working on a treatment option for “advanced solid tumors.” “Forty percent of Americans will be diagnosed with cancer at some point in their lifetime, so it will touch us all in one way, shape or form,” Sklavos said.  

Deb Krier on Leading During Cancer Treatment (The Price and Value Journey, Episode 152) When the leader is in treatment, the business still needs direction. On this episode of The Price and Value Journey, host John Ray welcomes Deb Krier, entrepreneur, cancer advocate, host of The Business Power Hour, and founder of TryingNotToDie.LIVE. Drawing on more […]

Over the last five years, billions of people have received at least one dose of a COVID-19 mRNA vaccine. New research has found an unanticipated result of these vaccines: Cancer treatments are more effective for some vaccinated patients, and many live longer than their unvaccinated counterparts. This news comes at a time where the federal government is slashing funding for mRNA research. Host Ira Flatow speaks to lead study author Adam Grippin and vaccine expert Eric Topol.Guests: Dr. Adam Grippin is a radiation oncologist at the MC Anderson Cancer Center in Houston, Texas. Dr. Eric Topol is a cardiologist and genomics professor at the Scripps Research Institute in La Jolla, California.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

In this deeply inspiring episode of Keeping Abreast, Dr. Jenn Simmons welcomes Dr. Pete Sulack—chiropractor, functional medicine practitioner, and founder of Unhealthy Anonymous—for a powerful conversation about defying the odds after a terminal cancer diagnosis.Dr. Sulack shares how he turned a death sentence into a journey of hope, healing, and renewal. Through faith, nutrition, and lifestyle transformation, he reclaimed his health and now guides others to do the same. Together, he and Dr. Jenn challenge conventional cancer paradigms, exploring how mindset, personalized nutrition, and spiritual alignment can unlock the body's innate capacity to heal.This episode invites listeners to rethink what's possible in cancer recovery and beyond. It's a story of courage, resilience, and faith in both science and spirit—reminding us that health is not something we outsource but something we build from within.In This Episode, You Will Learn:How Dr. Sulack overcame a terminal brain cancer diagnosisWhy functional medicine focuses on healing the whole person, not just treating diseaseThe crucial role of personalized nutrition in recoveryHow food sensitivities and gut health shape overall wellnessWhy conventional medicine often overlooks the importance of dietThe link between faith, mindset, and the body's innate ability to healHow to take proactive responsibility for your healthWhy empowerment and education can change the cancer care paradigm

Send us a textCould exercise be just what the doctor ordered for recovery during chemotherapy? In this episode of “The UMB Pulse,” explore this novel approach to cancer recovery with Ian Kleckner, PhD, MPH, associate professor at the University of Maryland School of Nursing and director of the SYNAPSE Center. Kleckner shares how exercise can alleviate symptoms of chemotherapy-induced peripheral neuropathy and improve the quality of life for cancer survivors. Through his research, Kleckner investigates how movement can reduce inflammation, enhance brain and body coordination, and empower patients to reclaim their lives. Chapter Markers 00:00 – Introduction 00:00:17 – Cancer Treatment & Neuropathy 00:01:37 – Guest Introduction: Dr. Ian Kleckner 00:05:06 – Understanding Neuropathy 00:09:38 – Research Findings: Brain & Exercise 00:13:33 – Exercise Intervention & Clinical Trials 00:19:08 – Practical Advice & Takeaways 00:23:31 – Conclusion & CreditsListen to The UMB Pulse on Apple, Spotify, Amazon Music, and wherever you like to listen. The UMB Pulse is also now on YouTube.Visit our website at umaryland.edu/pulse or email us at umbpulse@umaryland.edu.

Dr. Stacy Lindborg, President and CEO of IMUNON, has developed a DNA-based immunotherapy candidate for the treatment of ovarian cancer. This therapy works by administering the drug, which utilizes IL-12, a powerful anti-cancer cytokine, directly into the cavity where the cancer resides, thereby affecting the tumor microenvironment. Trials are showing that the drug can produce significant life extension when used in combination with standard chemotherapy. Stacy explains, "There are about 300,000 women who are newly diagnosed with advanced ovarian cancer every year, about 20,000 in the US, and the frontline standard of care hasn't seen a change in the treatment in about 25 years. So this is for newly diagnosed women. The very first treatment that they would have, which we call frontline treatment, is a platinum-based chemotherapy. So carboplatin and Paclitaxel are both administered through IV over an hour for carboplatin, about three hours for Paclitaxel. So most women go directly to chemotherapy and then surgery, and then chemotherapy. Some women will go straight to surgery and then have this chemotherapy afterwards."   "Our approach is a DNA-based immunotherapy candidate that we have in Phase 3. We refer to the lead candidate as IMNN-001, and this is a non-viral nanoparticle that is administered directly into the cavity of interest. So, what we call the micro-tumor environment is the peritoneal cavity, where the cancer actually resides, and it's delivered through a catheter. And it basically has a very powerful anti-cancer fighting cytokine, IL-12, that is encoded in this immunotherapy. And it causes the cells that are within each woman's body, both cancer and non-cancer alike, to start producing activities that will help fight these complex cancer cells that exist."  #IMUNON #OvarianCancer #DNABasedImmunotherapy #WomensHealth #CancerAwareness  imunon.com Download the transcript here

Dr. Stacy Lindborg, President and CEO of IMUNON, has developed a DNA-based immunotherapy candidate for the treatment of ovarian cancer. This therapy works by administering the drug, which utilizes IL-12, a powerful anti-cancer cytokine, directly into the cavity where the cancer resides, thereby affecting the tumor microenvironment. Trials are showing that the drug can produce significant life extension when used in combination with standard chemotherapy. Stacy explains, "There are about 300,000 women who are newly diagnosed with advanced ovarian cancer every year, about 20,000 in the US, and the frontline standard of care hasn't seen a change in the treatment in about 25 years. So this is for newly diagnosed women. The very first treatment that they would have, which we call frontline treatment, is a platinum-based chemotherapy. So carboplatin and Paclitaxel are both administered through IV over an hour for carboplatin, about three hours for Paclitaxel. So most women go directly to chemotherapy and then surgery, and then chemotherapy. Some women will go straight to surgery and then have this chemotherapy afterwards."   "Our approach is a DNA-based immunotherapy candidate that we have in Phase 3. We refer to the lead candidate as IMNN-001, and this is a non-viral nanoparticle that is administered directly into the cavity of interest. So, what we call the micro-tumor environment is the peritoneal cavity, where the cancer actually resides, and it's delivered through a catheter. And it basically has a very powerful anti-cancer fighting cytokine, IL-12, that is encoded in this immunotherapy. And it causes the cells that are within each woman's body, both cancer and non-cancer alike, to start producing activities that will help fight these complex cancer cells that exist."  #IMUNON #OvarianCancer #DNABasedImmunotherapy #WomensHealth #CancerAwareness  imunon.com Listen to the podcast here

Today, People Before Profit TD Richard Boyd Barrett was welcomed back into the Dáil after recovering from throat cancer.He took the opportunity to call for cancer services to be properly resourced and supported in his first speech back.Richard joins Ciara Doherty in the studio to discuss.

Today's guest is Lashelle Scott, breast cancer survivor, advocate, and policy administrator. She champions awareness, equity, and legislation, serving as an ambassador for the Susan G. Komen Cener for Public Policy and the American Cancer Society.We talk about healthcare and the financial burdens placed on so many, policy changes that are worth fighting for, the importance of funding for research, and so much more.No matter what side of the political aisle you align with, the truth is that cancer treatments are expensive and something needs to change. Conversations like this are an important step, along with the work Lashelle and so many others are doing. Resources:Lashelle's Facebook: https://www.facebook.com/thefutureSenatorScottLashelle's Instagram: https://www.instagram.com/senatornorthstar2021/Lashelle's Email: the.hope.project.initiative@gmail.comFollow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

Jim Foote, CEO and Founder of First Ascent Biomedical a pioneer in functional precision medicine (FPM) that aims to eliminate guesswork from cancer treatment. After losing his son to cancer, Jim left a career in cybersecurity to build a data-driven platform that combines AI, robotics and real-time tumour testing to help doctors choose the right therapy for each patient. In this episode, we explore how FPM differs from traditional genomics-only testing, why tumours can respond differently even with the same patient and how AI can support rather than replace clinicians in treatment decisions. Jim also shares the economic impact of ineffective therapies, the challenges of scaling regulatory innovation in oncology, and why the future of cancer care depends on personalisation at the  cellular level.Timestamps:[00:00:45] What Is Functional Precision Medicine?[00:02:00] Jim's Personal Journey from Tech to Healthcare[00:05:50] Overcoming Regulatory and Systemic Gatekeepers[00:08:13] From Reactive Care to Personalised Treatment[00:09:08] What Lab Findings Reveal about Cancer Cells[00:10:30] Why Genomics Alone Isn't Enough[00:12:03] AI as Decision Support Not a Decision Maker[00:15:55] Cancer in Younger Populations and Misconceptions[00:20:25] Reducing Cost and Waste in Cancer Treatment[00:26:34] What Success Really Means to Jim FooteConnect with Jim - https://www.linkedin.com/in/jim-foote/ Learn more about First Ascent Biomedical - https://www.linkedin.com/company/firstascentbio/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwalSubscribe to the Podcast

Receipt of an mRNA vaccine for Covid within 100 days of beginning immunotherapy for lung cancer or melanoma increased a person's survival likelihood by a factor of two or greater, a new study shows. Johns Hopkins mRNA expert Jeff Coller … Might mRNA vaccines replace chemotherapy for cancer treatment? Elizabeth Tracey reports Read More »

People with lung cancer or melanoma who were receiving immunotherapy and got a Covid vaccine within 100 days of initiating treatment saw dramatically improved survival compared to those folks who did not receive a vaccine, a new study shows. mRNA … The benefit of mRNA vaccines in cancer treatment is ongoing, Elizabeth Tracey reports Read More »

Welcome back to Navigating Cancer TOGETHER! We're picking up right where we left off with the remarkable Peta-Ann Wood, a breast cancer thriver and Soulful Coach.Part 1, "Choosing Flat: Peta-Ann's Journey to Self-Acceptance," was about the courage to choose (flatness, self-advocacy, and leaving people-pleasing behind). Now, Part 2 is the roadmap for flourishing once those massive decisions are made.Peta-Ann opens up about the powerful shift from managing her life to becoming a Happiness Coach. She reveals how her personal journey, touching on her late AuDHD diagnosis and her life-affirming choice to go flat, gave her a unique lens for helping others find inner peace and contentment.If you are struggling with the transition after treatment ends, or if you feel like your self-worth took a hit during your diagnosis, this episode is dedicated to you. Peta-Ann shares candid advice and heartwarming success stories that prove recovery isn't just about survival, it's about building a happier life than you had before.✨Episode Highlights:03:36 Understanding the shift: Why Peta-Ann focused on Happiness Coaching.08:47 How Lived Experience fuels her personal growth and guidance.16:28 Navigating Cancer TOGETHER: A reflection on building genuine community support.26:49 Words of Encouragement: Direct, honest advice for the cancer community.Transcript: https://bit.ly/podscript175Part I: https://podcast.ausha.co/navigatingcancertogether/choosing-flat-peta-ann-s-journey-to-self-acceptanceConnect & Engage with Peta-Ann:Website: https://www.elegantrebelponders.comInstagram: https://www.instagram.com/elegant.rebel.pondersFacebook: https://www.facebook.com/ElegantRebel44Call to Action & Community:If Peta-Ann's adventure resonated with you, or you know someone else needs to hear this transformative conversation, please share this episode! Text the link to a fellow survivor, patient, or caregiver who could use a dose of guidance and hope today.Don't miss the next human-centered conversation! Subscribe or follow Navigating Cancer TOGETHER on your favorite podcast app or platform to ensure you get immediate alerts for every new episode.Join the Waitlist: Get ready to connect with a supportive community! Join the waitlist for our Navigating Cancer TOGETHER forum here: https://www.ontheotherside.life/forum-waitlistHosted, Produced, Written, and Edited by: Talaya DendyDisclaimer: The information on this podcast is for general informational purposes only and SHOULD NOT be used as a substitute for sound professional medical advice, evaluation, or care from your physician or other qualified health care provider.Hosted by Ausha. See ausha.co/privacy-policy for more information.

Here I explain the lymphatic system, a crucial bodily network for overall health and appearance. I explain how the lymphatic system works to remove cellular waste and fluid from your organs and combat infections. I provide science-based tools that support your lymphatic system for the sake of health and appearance, including: how to reduce fluid retention in your limbs, trunk or face, how to eliminate 'bags' under your eyes and brain fog, and how to improve cardiac health and longevity. Because your lymphatic system lacks a central pump, it needs the mechanical forces generated by specific types of bodily movement, breathing and pressure to circulate your lymph properly, and I explain how you can activate these. I also explain how to support optimal functioning of your glymphatic system, a brain- and spinal cord waste-clearing system active during sleep that is crucial for brain functioning and longevity, including to prevent dementia. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AGZ by AG1: https://drinkagz.com/huberman LMNT: https://drinklmnt.com/huberman David: https://davidprotein.com/huberman Eight Sleep: https://eightsleep.com/huberman Function: https://functionhealth.com/huberman Timestamps (00:00:00) Lymphatic System (00:04:11) Circulatory System, Heart; Oxygen, Nutrient & Waste Transfer (00:11:03) Lymphatic System, Fluid, Lymphedema, Chronic Inflammation; Brain Fog (00:14:52) Sponsor: LMNT & David Protein (00:17:28) Lymphatic Vessels, Tool: Enhance Lymphatic Drainage with Movement (00:26:24) Tools: Jumping (Rebounding), Treading Water, Swimming (00:27:41) Tool: Swelling, Lymphatic Drainage & Diaphragmatic Breathing (00:32:05) Swimming & Lymphatic Flow; Tai Chi (00:34:00) Lymphatic Massage, Cancer & Lymphedema; Jade Roller & Gua Sha (00:37:28) Sponsor: AGZ by AG1 (00:38:56) Lymph Flow, Tool: Lymphatic Massage & Manual Lymphatic Drainage (00:45:02) Immune Function of Lymphatic System, Sore Lymph Nodes (00:54:24) Cancer Treatment, Lymph Nodes & Lymphedema (00:57:02) Limb Swelling, Minor Lymphedema & Inflammation, Lymphatic Boots (01:00:09) Sponsors: Eight Sleep (01:01:43) Glymphatic System, Brain & Sleep (01:05:56) Sleep & Brain Waste Recycling; Discovery of the Glymphatic System (01:12:24) Enhance Glymphatic Clearance, Brain Fog, Age, Tool: Side Sleeping Position (01:15:54) Tools: Optimize Sleep, Cardiovascular Exercise, Elevate Feet, Pillow (01:17:29) Puffy Face, Tool: Lymphatic & Facial Massage (01:21:23) Sponsor: Function (01:23:11) Tool: Hydration & Lymphatic Support (01:24:48) Tool: Cardiovascular Exercise & Lymphatic Vessels, Heart, Aging (01:31:06) Tool: Infrared & Red Light, Mitochondria, Lymphedema, Skin Appearance (01:36:08) Key Takeaways (01:37:21) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

It's a cancer treatment breakthrough that could save lives and doctors want it available to everyone.

It's a cancer treatment breakthrough that could save lives and doctors want it available to everyone.

Welcome to a special bonus episode of YXE Underground. My name is Eric Anderson and it has been a busy week for the podcast.Last Monday, I dropped an episode that took listeners to Beaver Creek Conservation Area to enjoy a Dark Skies event put on by the Meewasin Valley Authority.On Thursday, I spoke with Katayoon Navabi about the Diaspora Film Festival she was helping organize at the Remai Modern. I saw a great documentary yesterday as part of the film festival called Allihopa: The Dalkurd Story. My congrats to Katayoon and her team for putting on such a wonderful event. Today, I am sharing a conversation about an upcoming fundraising event that has raised more than three million dollars since 2007.Choc'la Cure is a non-profit organization dedicated to raising funds to purchase cancer treatment equipment used at the Saskaoon Cancer Centre. It formed 18 years ago and has impacted the lives of so many people in Saskatoon and throughout our province.Choc'la Cure's annual gala event takes place on November 7th at Dutch Growers, and I learned more about the organization and its impact on the Saskatoon Cancer Centre thanks to Kim Swiatecki, Breanne Cooper and Dr. John DeCoteau. Kim is a volunteer on the Choc'la Cure committee and a previous guest on the podcast way back in season one. Breanne is the Chair of Choc'la Cure, and Dr. DeCoteau is the Medical Director of the Advanced Diagnostic Research Lab at the Saskatoon Cancer Centre. The goal of this year's gala is to raise money for a new piece of medical equipment for the Cancer Centre, which Dr. DeCoteau explains in fascinating detail in our conversation. I met Kim, Breanne and Dr. DeCoteau at Citizen Café a few weeks ago and learned so much from all of them. Best of luck to the entire Choc'la Cure team on their upcoming fundraiser!Listen and follow YXE Underground wherever you find your favourite podcasts including Apple Podcasts, Spotify, and YouTube. Please feel free to leave a 5-star review if you enjoyed this episode. I would greatly appreciate it.Cheers...Eric      Host, Producer, Editor: Eric AndersonTheme Music: Andrew DicksonWebsite: https://www.yxeunderground.comRecorded: On Treaty 6 Territory and the traditional homeland of the Metis

TWiV explains studies showing that SARS-CoV-2 mRNA vaccines improve life span of cancer patients on checkpoint immunotherapy, and broad immunity conferred by a vaccine central in A(H5) influenza antigenic space. Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Immune 100 live at the Incubator SARS-CoV-2 mRNA vaccines sensitize tumors to checkpoint immunotherapy (Nature) People with some cancers live longer after mRNA vaccines (Nature) Immune checkpoint inhibitors (NCI) Broad immunity from influenza H5 vaccine (Nature) Derek Smith on antigenic cartography (TWiV 99 at 2:53) Letters read on TWiV 1265 Timestamps by Jolene Ramsey. Thanks! Weekly Picks Kathy – Permethrin-treated baby wraps for malaria prevention and Phil Sharp and the Biotech Revolution Rich – Lydia Fairchild; Tetragametic Chimerism (NEJM) Alan – Warning Signs Vincent – radio.garden thanks to Kim! Listener Pick Jamie – SkyCards by Flightradar24 Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

In this episode of Hashtag Trending, host Jim Love discusses the Canadian CIO of the Year Awards and recognizes several winners. Highlights include OpenAI entering the browser market with ChatGPT-integrated Atlas, posing a serious threat to Google Chrome's dominance. Security concerns with Atlas storing OAuth tokens are mentioned, urging caution while experimenting with new AI browsers. Additionally, the Glassworm malware hiding in Visual Studio Code extensions is detailed, highlighting the importance of auditing extensions. Finally, an AI model collaboration between Google and Yale University shows promising results in cancer treatment by making tumors more visible to the immune system. Tune in for these updates and more! 00:00 Shoutout to CIO Achievements 01:56 Introducing Hashtag Trending 02:02 OpenAI's New Browser: Atlas 04:14 Security Alert: Glass Worm in VS Code 06:37 AI Breakthrough in Cancer Treatment 08:25 Closing Remarks and How to Support Us

Prominent colorectal surgeon Frank Frizelle says it is now a necessity for dedicated cancer centres in New Zealand. The Christchurch-based surgeon believes if New Zealand does not adopt comprehensive cancer centres, the system will fail patients. Frizelle told Heather du Plessis-Allan, "it's just about trying to give adequate volumes and concentrations of resources to try and get the best value for money". LISTEN ABOVESee omnystudio.com/listener for privacy information.

In this honest and empowering episode of Navigating Cancer TOGETHER, host Talaya Dendy sits down with the phenomenal Peta-Ann Wood, breast cancer thriver, Soulful Coach, and creator of Elegant Rebel.This conversation goes beyond the clinical. Peta-Ann openly shares how a late diagnosis of AuDHD (Autism + ADHD) changed her cancer experience, guiding her from people-pleasing straight toward radical self-discovery.If you've ever felt pressure to make a decision about reconstruction, treatment, or even just how you should feel, this episode is your permission slip. Peta-Ann dives into the emotional process that led her to the definitive and life-changing choice to remain flat after her bilateral mastectomy.This is a must-listen for anyone in the cancer community who is questioning, redefining, or simply trying to prioritize their own needs and desires amidst the chaos of illness.✨Episode Highlights:02:21 Peta-Ann's Unique Journey: Navigating cancer alongside a late AuDHD diagnosis.07:40 The Shift: How life after diagnosis became about prioritizing her needs.12:23 Self-Advocacy Unlocked: Learning to trust intuition in a complex medical system.24:48 Beyond the Diagnosis: Understanding Neurodivergence and the End of People-Pleasing.29:40 The Definitive Choice: The transformative conversation about choosing to stay flat.38:35 Writing Her Truth: Insights into her book, What Happens When They Don't Go Back.Transcript: https://bit.ly/podscript174Connect & Engage with Peta-Ann:Website: https://www.elegantrebelponders.comInstagram: https://www.instagram.com/elegant.rebel.pondersFacebook: https://www.facebook.com/ElegantRebel44Resources & Call to Action:In honor of the movement: October 7th was International Flat Day, a global moment celebrating the beautiful choice of aesthetic flat closure. Learn more and connect: https://www.facebook.com/InternationalFLATDay/Connect with Your Community: Don't navigate this journey alone. Join the waitlist for our "Navigating Cancer TOGETHER" forum and connect with others who truly get it. https://www.ontheotherside.life/forum-waitlistSubscribe or follow Navigating Cancer TOGETHER on your favorite podcast app or platform so you never miss a vital conversation.Hosted, Produced, Written, and Edited by: Talaya DendyDisclaimer: The information on this podcast is for general informational purposes only and SHOULD NOT be used as a substitute for sound professional medical advice, evaluation, or care from your physician or other qualified health care provider.Hosted by Ausha. See ausha.co/privacy-policy for more information.

Pippa Hudson speaks to Samantha Loggenberg, who is a University of Pretoria PhD candidate, an is among eight female scientists awarded The L’Oréal-UNESCO For Women in Science Award for her investigation of South African medicinal plants to find new compounds that could help treat triple-negative breast cancer. Lunch with Pippa Hudson is CapeTalk’s mid-afternoon show. This 2-hour respite from hard news encourages the audience to take the time to explore, taste, read and reflect. The show - presented by former journalist, baker and water sports enthusiast Pippa Hudson - is unashamedly lifestyle driven. Popular features include a daily profile interview #OnTheCouch at 1:10pm. Consumer issues are in the spotlight every Wednesday while the team also unpacks all things related to health, wealth & the environment. Thank you for listening to a podcast from Lunch with Pippa Hudson Listen live on Primedia+ weekdays between 13:00 and 15:00 (SA Time) to Lunch with Pippa Hudson broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/MdSlWEs or find all the catch-up podcasts here https://buff.ly/fDJWe69 Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

GT Biopharma (NASDAQ: GTBP) is pioneering a new era in cancer treatment: one that replaces cutting, burning, and poisoning with precision, safety, and the power of the body's own immune system.In this interview, Executive Chairman & CEO Michael Breen and Consulting Senior Medical Director Dr. Jeffrey Miller discuss how GT Biopharma's TriKE® technology harnesses natural killer (NK) cells to target and destroy cancer cells, offering a more humane alternative to traditional therapies. They talk about the science behind their platform, the progress of ongoing Phase 1 clinical trials for blood cancer, upcoming FDA filings for solid tumors, and how next-generation nanobody and camelid technology is advancing efficacy and safety.Discover why GT Biopharma's platform represents one of the most promising innovations in immunotherapy and why investors are watching closely as key data milestones approach.Learn more about GT Biopharma: https://www.gtbiopharma.com/Watch the full YouTube interview here: https://youtu.be/he9i0aJQ2JMAnd follow us to stay updated: https://www.youtube.com/@GlobalOneMedia

Rachel Cliffe, Community Outreach and Partnerships Manager at Siteman Cancer Center, discusses her role in cancer prevention and community education. She highlights the importance of healthy habits like eating well, exercising, and avoiding smoking to reduce cancer risk. Rachel shares her experience with recent partnerships with local businesses in St. Louis to help raise cancer awareness. Check out St. Louis Mom's latest reel of Ovarian Cancer Prevention in partnership with Siteman Cancer Center!This podcast episode is sponsored by Siteman Cancer Center: National Leaders in Cancer Treatment & Research.Rachel Cliffe is a Telly Award–winning producer at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, where she's spent seven years advancing the organization's mission to educate and empower the St. Louis community on cancer prevention and early detection. As Community Outreach & Partnerships Manager, Rachel develops innovative collaborations with local organizations, businesses, venues, and community groups to promote healthier lifestyles and raise awareness about the critical importance of early and routine cancer screenings. She also leads production of Siteman's award-winning podcast, ‘This Is Cancer', a patient-centered series featuring conversations with WashU Medicine physicians that aim to inform, uplift, and support individuals navigating cancer treatment, caregiving, and beyond. Outside of work, Rachel enjoys taking her kids to local parks, cooking, spending time with friends and family, and discovering new restaurants in St. Louis.We hope you enjoyed this podcast episode! To learn more about Moms of the Lou you can go to stlouismom.com or follow us on Instagram and Facebook. You can listen to the podcast on Apple Podcast and Spotify. And don't forget to rate and review so more people can tune in! This episode was produced by the St. Louis Mom. It was recorded and edited by STL Bucketlist Studios in St. Louis, Missouri. 

Dr. Patrick Quillin explores Nutrition 5.0, an innovative approach that places diet at the forefront of cancer therapy. Discover scientifically validated dietary strategies that enhance treatment outcomes, improve quality of life, and support long-term recovery. #CancerNutrition #IntegrativeHealth #HealingFoods

The advent of artificial light is obliterating women's moon-driven menstrual cycle rhythms; When the triple whammy of cataracts, glaucoma, and macular degeneration strikes; Why can systolic blood pressure spike erratically? Are wrist and finger wearables for blood pressure ready for prime time? Nearly half of drivers killed in crashes have THC in their blood; Drinking bottled water causes surge in plastic micro-particle intake; The common supplement that can supercharge cancer immunotherapy.

TALK ME OUT OF IT UPDATE: I Need To Borrow From My Friend's Cancer Treatment Fund full 256 Mon, 13 Oct 2025 13:57:24 +0000 kOCqRX74U1vj5I8qABJ7g9ByZlQjSQpb advice,kramer and jess,talk me out of it update,moral dilemma,music,society & culture,news Kramer & Jess On Demand Podcast advice,kramer and jess,talk me out of it update,moral dilemma,music,society & culture,news TALK ME OUT OF IT UPDATE: I Need To Borrow From My Friend's Cancer Treatment Fund Highlights from the Kramer & Jess Show. 2024 © 2021 Audacy, Inc. Music Society & Culture News False https://pla

Clinical trials pave the way for new breast cancer treatments, but many patients hesitate to take part. Dr. Ahmed Elkhanany returns to the show to break down what these studies really mean and why access and education make a difference. What clinical trials are and how they work for patients Why every standard medicine starts with a trial How learning and access change treatment for everyone Key Questions Answered What is a clinical trial? Why do we need clinical trials? How do clinical trials progress from phase one to phase four? Why is it often difficult to get people to participate in clinical trials? How do you address patient skepticism towards clinical trials? Who decides if a new drug’s benefit is worth its risks? How do drug approval processes in the United States differ from those in Europe? What are the potential benefits for patients who participate in clinical trials? How do you approach a patient when recommending a clinical trial, especially if standard treatments have failed? What support systems exist to help patients participate in clinical trials, especially those traveling long distances or facing financial barriers? Timestamped Overview 00:00 Understanding Clinical Trials Stages 06:10 Advancing Medicine Through Clinical Trials 07:49 Cancer Treatment Decision Challenges 12:03 Global Drug Trial Decision Process 16:31 Immunotherapy Breakthrough in Cancer Treatment 20:10 Clinical Trials: Challenges and Importance 23:52 Key Patient Advice: Second Opinions 26:01 Bridging Clinical Trial Accessibility 29:05 Advancements Reducing Breast Cancer Mortality Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts.See omnystudio.com/listener for privacy information.

Clinical trials pave the way for new breast cancer treatments, but many patients hesitate to take part. Dr. Elkhanany breaks down what these studies really mean and why access and education make a difference. What clinical trials are and how they work for patients Why every standard medicine starts with a trial How learning and access change treatment for everyone Key Questions Answered What is a clinical trial? Why do we need clinical trials? How do clinical trials progress from phase one to phase four? Why is it often difficult to get people to participate in clinical trials? How do you address patient skepticism towards clinical trials? Who decides if a new drug’s benefit is worth its risks? How do drug approval processes in the United States differ from those in Europe? What are the potential benefits for patients who participate in clinical trials? How do you approach a patient when recommending a clinical trial, especially if standard treatments have failed? What support systems exist to help patients participate in clinical trials, especially those traveling long distances or facing financial barriers? Timestamped Overview 00:00 Understanding Clinical Trials Stages 06:10 Advancing Medicine Through Clinical Trials 07:49 Cancer Treatment Decision Challenges 12:03 Global Drug Trial Decision Process 16:31 Immunotherapy Breakthrough in Cancer Treatment 20:10 Clinical Trials: Challenges and Importance 23:52 Key Patient Advice: Second Opinions 26:01 Bridging Clinical Trial Accessibility 29:05 Advancements Reducing Breast Cancer Mortality Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts.See omnystudio.com/listener for privacy information.

AI Therapy: Can An Algorithm Help You More Than A Human? Will AI therapy promote even more isolation within society? Dr. Michael Heinz, a research psychiatrist, is part of a team using generative AI to act as a therapist for people with anxiety, depression, and eating disorders. Dr. Michael Heinz explains how this always-available AI therapist measures up to human-based therapy, and how AI best fits into the future of mental health.' Segment 2: CAR-T Cell Therapy: Pioneering The Future Of Cancer Treatment CAR T-cell therapy is a groundbreaking cancer treatment that reprograms a patient's own immune cells to recognize and destroy cancer. First approved by the FDA in 2017, it's already shown success in patients with blood cancers that no longer respond to standard treatments. While the therapy can cause serious side effects, our expert this week –a pioneer of this therapy– discusses the future of using this powerful new weapon against cancer. Learn more about your ad choices. Visit megaphone.fm/adchoices

CAR T-cell therapy is a groundbreaking cancer treatment that reprograms a patient's own immune cells to recognize and destroy cancer. First approved by the FDA in 2017, it's already shown success in patients with blood cancers that no longer respond to standard treatments. While the therapy can cause serious side effects, our expert this week –a pioneer of this therapy– discusses the future of using this powerful new weapon against cancer. Learn more about your ad choices. Visit megaphone.fm/adchoices

Managing Mental Health & Social Challenges After Cancer Treatment with guest Dr. Nancy Borstelmann October 12, 2025 Yale Cancer Center visit: https://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

TALK ME OUT OF IT: I Need To Borrow From My Friend's Cancer Treatment Fund full 772 Thu, 09 Oct 2025 14:29:19 +0000 sTc8x0TldfArhpq740obzL5KwfoPK8Yi advice,talk me out of it,borrow money,moral dilemma,music,society & culture,news Kramer & Jess On Demand Podcast advice,talk me out of it,borrow money,moral dilemma,music,society & culture,news TALK ME OUT OF IT: I Need To Borrow From My Friend's Cancer Treatment Fund Highlights from the Kramer & Jess Show. 2024 © 2021 Audacy, Inc. Music Society & Culture News False https://player.amp

Zulma Williams: Inspiring Cancer Survivors Through Advocacy and Tenacity In this inspiring and essential episode of Navigating Cancer TOGETHER, host Talaya Dendy welcomes special guest Zulma Williams, a licensed clinical social worker and inspiring breast cancer survivor.Zulma shares her compelling personal journey: from immigrating to the U.S. and pursuing higher education later in life, to her personal journey through breast cancer treatment and recovery.This conversation is a vital resource for anyone facing a health challenge, focusing on the critical role of the patient.In this episode, you will gain crucial insights on:Self-Advocacy: Why being an informed and proactive patient is the most important step in your healthcare journey.Mental Well-being: Zulma's expertise on navigating anxiety, depression, and shared trauma during and after treatment.The Power of Attitude: Advice on setting boundaries, prioritizing self-care, and maintaining a positive mindset through life-altering challenges.Zulma's story and clinical experience blend to offer a powerful message of hope, tenacity, and authenticity. Don't miss her actionable advice on finding your voice and transforming your experience into a source of strength.✨Episode Highlights:08:50 Zulma's Breast Cancer Diagnosis and Treatment Journey20:38 KEY TOPIC: The Paramount Importance of Self-Advocacy in Healthcare30:55 Zulma's Insights: Addressing Anxiety, Depression, and Trauma in Recovery36:44 Practical Tips: Setting Boundaries and Prioritizing Self-Care38:25The Power of Attitude and Affirmations in Healing56:35Discussing Cultural Perspectives on Illness and Seeking TherapyTranscript: https://bit.ly/podscript173Connect & Engage with Zulma:Website & podcast: https://www.dragonflytherapyservices.netInstagram: https://www.instagram.com/theswearingtherapist/Connect with NCT: nctpodcastfan@gmail.com, https://fanlist.com/nctpodcastSupport the new Survivor Series: A mission to uncover the unfiltered reality of survivorship. Learn more here: https://givebutter.com/SurvivorSerieswithTalayaDendyNavigating Cancer TOGETHER delivers heartfelt stories and expert insights to remind you that you are not alone. Subscribe now on Spotify, Apple Podcasts, YouTube, or your favorite podcast platform.Sponsor: This episode is brought to you by On the Other Side. Thank you for your support!Hosted, Produced, Written, and Edited by: Talaya DendyDisclaimer: The information on this podcast is for general informational purposes only and SHOULD NOT be used as a substitute for sound professional medical advice, evaluation, or care from your physician or other qualified health care provider.Hosted by Ausha. See ausha.co/privacy-policy for more information.

If you have a friend or family member diagnosed with cancer or another serious illness, all you want to do is help. But where do you start? What if you say the wrong thing or don't show up in the right ways? In this episode, we go over different ways to offer support. No matter what your strengths are, we have ideas to get you started.Sign up for our newsletter series on credit card debt.  Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

If you have a friend or family member diagnosed with cancer or another serious illness, all you want to do is help. But where do you start? What if you say the wrong thing or don't show up in the right ways? In this episode, we go over different ways to offer support. No matter what your strengths are, we have ideas to get you started.Sign up for our newsletter series on credit card debt.  Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Today, Ivelisse welcomes Dr. Francisco Contreras, renowned surgical oncologist and Director, President, and Chairman of Oasis of Hope Hospital. Together, they dive into the world of integrative cancer care with a special focus on ozone therapy—a treatment that improves oxygenation, supports immune function, and works alongside conventional therapies to enhance healing outcomes.Dr. Contreras shares how ozone therapy is administered, its unique benefits, and compelling patient success stories that highlight its role in strengthening the body during cancer treatment. He also opens up about the broader philosophy of Oasis of Hope, which bridges conventional and complementary medicine to provide individualized and compassionate cancer care.Beyond the science, Dr. Contreras emphasizes the surprising yet critical connection between happiness and health, and he and Ivelisse explore how cultivating joy can impact recovery. The conversation also touches on the limitations of traditional U.S. cancer treatments and how Oasis of Hope offers a more holistic, patient-centered path.Listeners will walk away with practical insights into how ozone therapy can boost healing, strengthen the immune system, and fit into a broader integrative approach to cancer care.Learn more about Dr. Francisco Contreras and Oasis of Hope:https://www.oasisofhope.com/Suggested Resources:Ozone Treatments at Oasis of HopeOasis of Hope ExperienceBOOK:  The Art and Science of Undermining CancerBOOK:  Beating Cancer: 20 Natural, Spiritual and Medicinal RemediesOzone Oil/Cream Send us Fan Mail! Click here >Your donations power our podcast's mission to support cancer patients with hope, insights, and resources. Every contribution fuels our ability to uplift and empower. Join us in making a lasting impact. Donate now!

It is essential for adolescents and young adults (AYAs) to have a foundation of care prior to discharge after their cancer treatment, and the multidisciplinary care team, including primary care providers (PCPs), must be equipped to support these patients. In this episode, CANCER BUZZ speaks with Scott J. Capozza, PT, MSPT, on his journey navigating care after cancer treatment as a young adult and his ASCO JCO Oncology Practice article, “Patient is Otherwise Healthy.” CANCER BUZZ then speaks with Melody Griffith, MSW, LMSW, Outpatient Adolescent and Young Adult (AYA) Oncology social worker at Mayo Clinic Arizona, on her role in patient navigation and how her department supports AYAs through their entire cancer continuum. CANCER BUZZ concludes with Cathy Lee-Miller, MD, director of AYA Oncology Clinic at the University of Wisconsin Carbone Cancer Center, on their cohort training program preparing PCPs for managing AYA survivorship care.    “The late effects for young adults are very real and a lot of times they are not recognized because we look otherwise healthy on the outside, but that belies what's going on internally.” - Scott J. Capozza, PT, MSPT   “We talk about post-traumatic stress, but also post-traumatic growth and what they bring with them and what they've learned through their process. It's not just the treatment, right? After treatment, there's a lot of years left to live.” - Melody Griffith, MSW, LMSW   “We really try and help empower these patients, particularly AYAs who maybe relied on their parents for their medical care before... We really try to spell that out for people so they can take responsibility and take charge of their own long-term health.” - Cathy Lee-Miller, MD   Scott J. Capozza, PT, MSPT Board Certified Clinical Specialist in Oncologic Physical Therapy  YNHH Outpatient Oncology Rehabilitation Services Smilow Cancer Hospital Adult Cancer Survivorship Clinic New Haven, CT   Melody Griffith, MSW, LMSW Outpatient Adolescent and Young Adult (AYA) Oncology Social Worker Mayo Clinic Arizona Phoenix, AZ   Cathy Lee-Miller, MD Director, AYA Oncology Clinic Associate Professor, Pediatric Hematology/Oncology/Transplant & Cellular Therapy University of Wisconsin Carbone Cancer Center Madison, WI    This podcast is part of the AYA Oncology Screening and Survivorship Services program, made possible through the support from The Arizona Clinical Oncology Society, Indiana Oncology Society, and Wisconsin Association of Hematology and Oncology. Resources: The Arizona Clinical Oncology Society: https://tacos.accc-cancer.org/resources/adolescent-and-young-adult-cancer-resources Indiana Oncology Society: https://inos.accc-cancer.org/resources/aya-cancer-resources Wisconsin Association of Hematology and Oncology: https://waho.accc-cancer.org/resources/adolescent-and-young-adult-cancer-resources

When someone finishes a cancer treatment, it can feel like the end of the story. For many, it may just be the beginning–risk of recurrence looms, long-term medications (and their side effects) begin, and it’s hard to get your bearings. What do you really need to know?In this candid conversation, Katie sits down with Dr. Lillian Smyth, Senior Vice President and Global Development Head for Breast Cancer at Eli Lilly and Company, and LaShae Rolle, a breast cancer survivor, public health researcher, and powerlifter. Together, they explore what life after breast cancer treatment really looks like: from follow-up care and managing side effects to navigating fears about recurrence and finding strength in advocacy.This episode—created in partnership with Eli Lilly—is about more than medicine. It’s about empowerment: knowing your “normal,” asking the right questions, and embracing life following cancer treatment.See omnystudio.com/listener for privacy information.

As lawmakers trade blame for the government shutdown, the economy is feeling the impact. Thousands of federal workers have been furloughed with firings potentially on the way. National Guard troops have been sent to Memphis. We have an update on twin hurricanes Imedla and Humberto. Plus, the Trump administration's initiative to end childhood cancer with AI. Learn more about your ad choices. Visit podcastchoices.com/adchoices